Volition Launches NU.Q™ Vet Cancer Screening Test At Texas A&M University
The easy-to-use, cost-effective tool will be offered through the Texas A&M College of Veterinary Medicine & Biomedical Sciences' Gastrointestinal (GI) Lab.
The easy-to-use, cost-effective tool will be offered through the Texas A&M College of Veterinary Medicine & Biomedical Sciences' Gastrointestinal (GI) Lab.
The test is now available to veterinarians in North America for use during annual wellness checks of older dogs, for cases where there is a suspicion of cancer, or for younger dogs from breeds with a high risk for developing cancer in their lifetimes.
Cancer is the most common cause of death in dogs over the age of 2 years in the U.S. Also, up to 50% of all dogs over the age of 10 develop cancer in their lifetime.
Cancer is the most common cause of death in dogs over the age of 2 years in the U.S. Also, up to 50% of all dogs over the age of 10 develop cancer in their lifetime.
Using a simple blood sample, the Nu.Q™ Vet Cancer Screening Test has been shown to detect
77%
82%
of lymphomas and
of hemangiosarcomas, two of the most common cancers in dogs that comprise approximately one-third of canine cancers.